|
Market Closed -
Other stock markets
|
Pre-market 03:00:00 | |||
| 496.50 USD | -0.39% |
|
498.66 | +0.43% |
| 07-09 | RBC Capital Adjusts Vertex Pharmaceuticals Price Target to $577 From $570 | MT |
| 07-08 | Biopharma Sector Seen Shifting to Fundamentals From Macro in H2, Morgan Stanley Says | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 28.62x | 5.75x | 2.09x | 8.65x | 19.51x | 20.35x | -.--% | 127B | |
| 35.46x | 21.54x | 0.72x | 12.91x | 26.29x | 27.16x | 0.56% | 1,084B | |
| 28.11x | 7.07x | -1.87x | 6.45x | 17.52x | 19.37x | 2.03% | 634B | |
| 30.45x | 1357.72x | 0.12x | 7.46x | 15.28x | 15.68x | 2.72% | 447B | |
| 17.81x | 6.62x | 1.03x | 4.43x | 10.97x | 12.3x | 2.99% | 330B | |
| 23.78x | 5.57x | 1.06x | 4.98x | 13.89x | 14.84x | 1.75% | 295B | |
| 21.66x | 6.48x | -47.47x | 5.57x | 13.46x | 14.72x | 2.83% | 285B | |
| 14.26x | 6.25x | -8.72x | 5.31x | 10.9x | 12.78x | 3.51% | 218B | |
| 24.07x | 18.47x | 3.24x | 6.37x | 11.22x | 14.58x | 2.74% | 199B | |
| -48.15x | 8.49x | 0.34x | 5.84x | 32.48x | 64.54x | 2.39% | 169B | |
| 11.77x | 1.56x | 0.23x | 3.02x | 7.45x | 8.6x | 7.28% | 137B | |
| 11.42x | 5.05x | 0.25x | 3.1x | 8.3x | 9.01x | 4.37% | 118B | |
| 12.7x | 4.57x | 1.22x | 2.78x | 8.15x | 9.23x | 3.52% | 105B | |
| 11.37x | 1.2x | 3.22x | 2.12x | 6.85x | 7.8x | 5.64% | 103B | |
| 23.76x | 5.38x | 1.38x | 8.05x | 15.23x | 15.93x | 1.86% | 74.31B | |
| 21.39x | 1.74x | -0.13x | 1.77x | 8.38x | 14.06x | 0.46% | 55.6B | |
| 44.32x | 1.17x | 54.18x | 2.7x | 9.92x | 27.49x | 3.75% | 52.94B | |
| 38.45x | 5.21x | 2.02x | 8.67x | 28.88x | 29.75x | 0.5% | 52.46B | |
| 42.76x | 20.32x | 0.19x | 7.19x | 32.68x | 31.76x | -.--% | 43.19B | |
| 18.77x | 1.89x | 4x | 3.42x | 12.83x | 14.4x | 2.2% | 42.83B | |
| Average | 20.64x | 74.60x | 0.86x | 5.54x | 15.51x | 19.22x | 2.56% | 228.54B | |
| Weighted average by Cap. | 23.57x | 142.25x | -2.27x | 7.32x | 17.43x | 20.01x | 2.2% |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
- Sector valuations
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
